The landscape of coronavirus disease 2019 (COVID-19) and integrated analysis SARS-CoV-2 receptors and potential inhibitors in lung adenocarcinoma patients

B Tang, J Zhu, Y Cong, W Yang, C Kong… - Frontiers in Cell and …, 2020 - frontiersin.org
The outbreak of novel coronavirus disease 2019 (COVID-19) has become the largest health
threat worldwide, with more than 34.40 million positive cases and over 1.02 million deaths …

The potential mechanism of cancer patients appearing more vulnerable to SARS-CoV-2 and poor outcomes: a pan-cancer bioinformatics analysis

X Huang, H Liang, H Zhang, L Tian, P Cong… - Frontiers in …, 2022 - frontiersin.org
To explore the potential mechanism of cancer patients appearing more vulnerable to SARS-
CoV-2 infection and poor COVID-19 outcomes, we conducted an integrative bioinformatics …

Bioinformatics and system Biology approach to reveal the interaction network and the therapeutic implications for non-small cell lung cancer patients With COVID-19

Z Zhuang, X Zhong, Q Chen, H Chen… - Frontiers in …, 2022 - frontiersin.org
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the leading
cause of coronavirus disease-2019 (COVID-19), is an emerging global health crisis. Lung …

Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on …

MN Uddin, R Akter, M Li, Z Abdelrahman - Chemico-Biological Interactions, 2021 - Elsevier
The aberrant expression level of SARS-CoV-2 cell receptor gene ACE2 was reported in lung
adenocarcinoma (LUAD) comorbidity of COVID-19. However, the association of ACE2 …

Unveiling the Biomarkers of Cancer and COVID-19 and Their Regulations in Different Organs by Integrating RNA-Seq Expression and Protein–Protein Interactions

N Ghosh, I Saha, D Plewczynski - ACS omega, 2022 - ACS Publications
Cancer and COVID-19 have killed millions of people worldwide. COVID-19 is even more
dangerous to people with comorbidities such as cancer. Thus, it is imperative to identify the …

Integrated bioinformatic analysis of SARS-CoV-2 infection related genes ACE2, BSG and TMPRSS2 in aerodigestive cancers

C He, X Hua, S Sun, S Li, J Wang… - Journal of Inflammation …, 2021 - Taylor & Francis
Background: Cancer patients are more vulnerable to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection than the general population, with lung epithelial cells …

Identifying potential gene defect patterns related to COVID-19 based on pharmacological and bioinformatics analysis for lung adenocarcinoma

H Lou, X Li, S Gao, Y Zhang, H Chen… - International journal of …, 2022 - Taylor & Francis
Abstract Background Coronavirus disease 2019 (COVID-19) greatly affects cancer patients,
especially those with lung cancer. This study aimed to identify potential drug targets for lung …

[HTML][HTML] Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational …

A Samad, T Jafar, JH Rafi - Genomics, 2020 - Elsevier
COVID-19 is a pandemic that began to spread worldwide caused by SARS-CoV-2. Lung
cancer patients are more susceptible to SARS-CoV-2 infection. The SARS-CoV-2 enters into …

[HTML][HTML] Evaluation of the susceptibility and fatality of lung cancer patients towards the COVID-19 infection: A systemic approach through analyzing the ACE2, CXCL10 …

TB Mahmood, AS Chowdhury, MU Hossain… - Current research in …, 2021 - Elsevier
Abstract Coronavirus disease-2019 (COVID-19) is a recent world pandemic disease that is
caused by a newly discovered strain of the Severe Acute Respiratory Syndrome …

Exploration of the Potential Link, Hub Genes, and Potential Drugs for Coronavirus Disease 2019 and Lung Cancer Based on Bioinformatics Analysis

Y Wang, Q Li, J Zhang, H Xie - Journal of oncology, 2022 - Wiley Online Library
The ongoing pandemic of coronavirus disease 2019 (COVID‐19) has a huge influence on
global public health and the economy. Lung cancer is one of the high‐risk factors of COVID …